{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:02:29Z","timestamp":1781067749234,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The study was supported by grants of the Berlin Institute of Health (BIH) and the DZHK","award":["FKZ 81Z2100202"],"award-info":[{"award-number":["FKZ 81Z2100202"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"DOI":"10.1007\/s10554-026-03685-x","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T07:59:23Z","timestamp":1774252763000},"page":"1183-1190","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Relationship between culprit lesion high-risk plaque features and adverse cardiovascular outcome at two years follow-up in patients with acute coronary syndrome. Insights from the OPTICO-ACS study"],"prefix":"10.1007","volume":"42","author":[{"given":"Gregor","family":"Nelles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef S.","family":"Abdelwahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Seppelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denitsa","family":"Meteva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukaram","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena M.","family":"Seegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Sieronski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Musfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Skurk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Haghikia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Klotsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara E.","family":"St\u00e4hli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Joner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Leistner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"3685_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fcvm.2020.00088","volume":"7","author":"DS Dhindsa","year":"2020","unstructured":"Dhindsa DS, Sandesara PB, Shapiro MD, Wong ND (2020) The evolving understanding and approach to residual cardiovascular risk management. Front Cardiovasc Med 7:88 (PubMed PMID: 32478100. Pubmed Central PMCID: PMC7237700. Epub 2020\/06\/02. eng.)","journal-title":"Front Cardiovasc Med"},{"issue":"19","key":"3685_CR2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/eurheartj\/ehu505","volume":"36","author":"T Jernberg","year":"2015","unstructured":"Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M (2015) Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. Eur Heart J 36(19):1163\u201370 (PubMed PMID: 25586123. Epub 2015\/01\/15. eng.)","journal-title":"Eur Heart J"},{"issue":"18","key":"3685_CR3","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","volume":"376","author":"MS Sabatine","year":"2017","unstructured":"Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA et al (2017) Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 376(18):1713\u201322 (PubMed PMID: 28304224. Epub 2017\/03\/18. eng.)","journal-title":"N Engl J Med"},{"issue":"35","key":"3685_CR4","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1093\/eurheartj\/ehy285","volume":"39","author":"L R\u00e4ber","year":"2018","unstructured":"R\u00e4ber L, Mintz GS, Koskinas KC, Johnson TW, Holm NR, Onuma Y et al (2018) Clinical use of intracoronary imaging Part 1: guidance and optimization of coronary interventions an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J 39(35):3281\u2013300","journal-title":"Eur Heart J"},{"issue":"12","key":"3685_CR5","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jacc.2011.09.079","volume":"59","author":"GJ Tearney","year":"2012","unstructured":"Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG et al (2012) Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol 59(12):1058\u201372","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"3685_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/eurheartj\/ehp433","volume":"31","author":"F Prati","year":"2010","unstructured":"Prati F, Regar E, Mintz GS, Arbustini E, Di Mario C, Jang IK et al (2010) Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 31(4):401\u201315","journal-title":"Eur Heart J"},{"issue":"38","key":"3685_CR7","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1093\/eurheartj\/ehad334","volume":"44","author":"T Gerhardt","year":"2023","unstructured":"Gerhardt T, Seppelt C, Abdelwahed YS, Meteva D, Wolfram C, Stapmanns P et al (2023) Culprit plaque morphology determines inflammatory risk and clinical outcomes in acute coronary syndrome. Eur Heart J 44(38):3911\u201325","journal-title":"Eur Heart J"},{"key":"3685_CR8","doi-asserted-by":"publisher","first-page":"117284","DOI":"10.1016\/j.atherosclerosis.2023.117284","volume":"385","author":"G Nelles","year":"2023","unstructured":"Nelles G, Abdelwahed YS, Alyaqoob A, Seppelt C, St\u00e4hli BE, Meteva D et al (2023) Spotty calcium deposits within acute coronary syndrome (ACS)-causing culprit lesions impact inflammatory vessel-wall interactions and are associated with higher cardiovascular event rates at one year follow-up: results from the prospective translational OPTICO-ACS study program. Atherosclerosis 385:117284 (PubMed PMID: 37871405. Epub 2023\/10\/24. eng.)","journal-title":"Atherosclerosis"},{"key":"3685_CR9","first-page":"131665","volume":"21","author":"G Nelles","year":"2023","unstructured":"Nelles G, Abdelwahed YS, Seppelt C, Meteva D, St\u00e4hli BE, Rai H et al (2023) Cholesterol crystals at the culprit lesion in patients with acute coronary syndrome are associated with worse cardiovascular outcomes at two years follow up - results from the translational OPTICO-ACS study program (R2). Int J Cardiol. 21:131665 (PubMed PMID: 38141724. Epub 2023\/12\/24. eng.)","journal-title":"Int J Cardiol."},{"issue":"3","key":"3685_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/eurheartj\/ehz520","volume":"41","author":"F Prati","year":"2020","unstructured":"Prati F, Romagnoli E, Gatto L, La Manna A, Burzotta F, Ozaki Y et al (2020) Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study. Eur Heart J. 41(3):383\u201391 (PubMed PMID: 31504405. Epub 2019\/09\/11. eng.)","journal-title":"Eur Heart J."},{"issue":"37","key":"3685_CR11","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1093\/eurheartj\/ehaa703","volume":"41","author":"DM Leistner","year":"2020","unstructured":"Leistner DM, Kr\u00e4nkel N, Meteva D, Abdelwahed YS, Seppelt C, St\u00e4hli BE et al (2020) Differential immunological signature at the culprit site distinguishes acute coronary syndrome with intact from acute coronary syndrome with ruptured fibrous cap: results from the prospective translational OPTICO-ACS study. Eur Heart J 41(37):3549\u201360","journal-title":"Eur Heart J"},{"issue":"20","key":"3685_CR12","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","volume":"33","author":"PG Steg","year":"2012","unstructured":"Steg PG, James SK, Atar D, Badano LP, Bl\u00f6mstrom-Lundqvist C, Borger MA et al (2012) ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33(20):2569\u2013619","journal-title":"Eur Heart J"},{"issue":"3","key":"3685_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F (2016) ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 37(3):267\u2013315","journal-title":"Eur Heart J"},{"issue":"12","key":"3685_CR14","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/ehjci\/jeab247","volume":"23","author":"YS Abdelwahed","year":"2022","unstructured":"Abdelwahed YS, Nelles G, Frick C, Seppelt C, Meteva D, St\u00e4hli BE et al (2022) Coexistence of calcified- and lipid-containing plaque components and their association with incidental rupture points in acute coronary syndrome-causing culprit lesions: results from the prospective OPTICO-ACS study. Eur Heart J Cardiovasc Imaging 23(12):1598\u2013605","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"3685_CR15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1161\/01.CIR.80.2.410","volume":"80","author":"E Braunwald","year":"1989","unstructured":"Braunwald E (1989) Unstable angina. A classification. Circulation 80(2):410\u2013414 (PubMed PMID: 2752565. Epub 1989\/08\/01. eng.)","journal-title":"Circulation"},{"issue":"24","key":"3685_CR16","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","volume":"137","author":"HM Garcia-Garcia","year":"2018","unstructured":"Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J et al (2018) Standardized end point definitions for coronary intervention trials: the Academic research consortium-2 consensus document. Circulation 137(24):2635\u201350 (PubMed PMID: 29891620. Epub 2018\/06\/13. eng.)","journal-title":"Circulation"},{"key":"3685_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.atherosclerosis.2016.02.010","volume":"247","author":"J Dai","year":"2016","unstructured":"Dai J, Tian J, Hou J, Xing L, Liu S, Ma L et al (2016) Association between cholesterol crystals and culprit lesion vulnerability in patients with acute coronary syndrome: an optical coherence tomography study. Atherosclerosis 247:111\u2013117 (PubMed PMID: 26897259. Epub 2016\/02\/22. eng.)","journal-title":"Atherosclerosis"},{"key":"3685_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.905363","volume":"9","author":"C Xue","year":"2022","unstructured":"Xue C, Chen Q, Bian L, Yin Z, Xu Z, Zhang H et al (2022) The relationships between cholesterol crystals, NLRP3 inflammasome, and coronary atherosclerotic plaque vulnerability in acute coronary syndrome: an optical coherence tomography study. Front Cardiovasc Med 9:905363 (PubMed PMID: 36386333. Pubmed Central PMCID: PMC9640760. Epub 2022\/11\/18. eng.)","journal-title":"Front Cardiovasc Med"},{"key":"3685_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ahj.2017.02.010","volume":"192","author":"R Waksman","year":"2017","unstructured":"Waksman R, Torguson R, Spad MA, Garcia-Garcia H, Ware J, Wang R et al (2017) The lipid-rich plaque study of vulnerable plaques and vulnerable patients: study design and rationale. Am Heart J 192:98\u2013104","journal-title":"Am Heart J"},{"issue":"20","key":"3685_CR20","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1016\/j.jacc.2017.03.556","volume":"69","author":"L Xing","year":"2017","unstructured":"Xing L, Higuma T, Wang Z, Aguirre AD, Mizuno K, Takano M et al (2017) Clinical significance of lipid-rich plaque\u00a0detected by optical coherence\u00a0tomography: a\u00a04-year follow-up study. J Am Coll Cardiol. 69(20):2502\u201313 (PubMed PMID: 28521888. Epub 2017\/05\/20. eng.)","journal-title":"J Am Coll Cardiol."},{"issue":"1","key":"3685_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2023.100759","volume":"3","author":"TA Pearson","year":"2024","unstructured":"Pearson TA, Vitalis D, Pratt C, Campo R, Armoundas AA, Au D et al (2024) The science of precision prevention: research opportunities and clinical applications to reduce cardiovascular health disparities. JACC Adv 3(1):100759","journal-title":"JACC Adv"},{"issue":"10","key":"3685_CR22","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41569-022-00687-9","volume":"19","author":"M Araki","year":"2022","unstructured":"Araki M, Park SJ, Dauerman HL, Uemura S, Kim JS, Di Mario C et al (2022) Optical coherence tomography in coronary atherosclerosis assessment and intervention. Nat Rev Cardiol 19(10):684\u2013703","journal-title":"Nat Rev Cardiol"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-026-03685-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-026-03685-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-026-03685-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:48:43Z","timestamp":1781066923000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-026-03685-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["3685"],"URL":"https:\/\/doi.org\/10.1007\/s10554-026-03685-x","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"YA receives consultancy fees from Boston Scientific and Shockwave. LMS received educational grants by Abbott Vascular and Terumo, honoraria lectures by Pfizer, Daichii Sankyo and Bristol Myers Squibb. CSk received financial support from Abbott, Boston Scientific, INARI and Shockwave. MJ reports personal fees from Abbott, AlchiMedics S.A.S., AstraZeneca, Biotronik, Medtronic, Recor Medical, Shockwave Medical, TRiCares, and Veryan; grants and personal fees from Boston Scientific, Cardiac Dimensions, and Edwards Lifesciences; and a grant from Infraredx. UL has received research grants from Abbott, MSD and Novartis, consulting fees from Novartis, Sanofi and Menarini as well as lecture and advisory honorary from Abott. DL received lecture honoraria from Amgen, Abott Vascular, AstraZeneca, and Novo Nordisk.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}